In her first OAR Director’s Blog post, Geri R. Donenberg, Ph.D., shares five takeaways from her recent conversation with NIH Director Jay Bhattacharya, M.D., Ph.D., on The Director’s Desk podcast, where they discussed the evolution of HIV prevention and treatment. An increased focus on implementation science is crucial to identify the best strategies to reach people in need of lifesaving HIV prevention and treatment interventions, she writes.

Did you miss October’s NIH Office of AIDS Research Advisory Council (OARAC) meeting? A meeting summary is now available! Meeting highlights included the introduction of Geri R. Donenberg, Ph.D. at her first meeting as OAR Director; a presentation by Wesley I. Sundquist, Ph.D., on how NIH-supported fundamental discoveries contributed to the development of an innovative HIV prevention drug, lenacapavir; and updates from OARAC task forces guiding the development of the next HIV strategic plan. Read the full meeting summary.

Join us on October 24, 2024, from 12-4:30 p.m. ET, for the 67th NIH Office of AIDS Research Advisory Council (OARAC) meeting. The meeting will feature the introduction of the next OAR Director Geri Donenberg, Ph.D. In addition, three OAR task forces will report their recommendations for the next NIH Strategic Plan for HIV and HIV-Related Research. Stay tuned for the full agenda. Watch live via NIH VideoCast.